We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OMER market cap is 255.23M. The company's latest EPS is USD -1.8740 and P/E is -2.17.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -35.71M | -40.9M | -48.15M | -39.77M | -39.03M |
| Net Income | -33.7M | -37.29M | -37.75M | -9.07M | -37.18M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 111.81M | 73.81M | 0 | 0 | 0 |
| Operating Income | -63.38M | -110.6M | -173.62M | -163.39M | -164.53M |
| Net Income | -84.49M | -138.06M | 194.24M | 47.42M | -117.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 560.13M | 527.42M | 493.07M | 378.27M | 437.49M |
| Total Liabilities | 505.2M | 506.91M | 507.02M | 403.25M | 508.82M |
| Total Equity | 54.94M | 20.51M | -13.95M | -24.98M | -71.33M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 136.97M | 181.04M | 419.27M | 590.97M | 378.27M |
| Total Liabilities | 245.99M | 301.79M | 395.49M | 505.29M | 403.25M |
| Total Equity | -109.02M | -120.75M | 23.78M | 85.68M | -24.98M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 174.54M | 142.2M | 109.55M | 74.73M | -41.78M |
| Investing | -181.33M | -145.96M | -88.79M | 27.45M | -61.93M |
| Financing | -388k | -648k | -1.13M | -106.08M | 98.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -60.07M | -100.09M | -109.72M | -86.48M | 74.73M |
| Investing | -3.4M | -67.03M | 193.71M | -127.56M | 27.45M |
| Financing | 60.7M | 174.53M | 6.32M | 124.25M | -106.08M |
| Market Cap | 255.23M |
| Price to Earnings Ratio | -2.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 36.02 |
| Price to Book Ratio | -10.24 |
| Dividend Yield | - |
| Shares Outstanding | 62.87M |
| Average Volume (1 week) | 498.13k |
| Average Volume (1 Month) | 375.29k |
| 52 Week Change | -35.56% |
| 52 Week High | 6.42 |
| 52 Week Low | 0.92 |
| Spread (Intraday) | 3.8 (56.72%) |
| Company Name | Omeros Corporation |
| Address |
3400 capitol blvd se tumwater, washington 98501 |
| Website | https://www.omeros.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
